Life science tech VC firm backs $420m SPAC

Anzu Special Acquisition Corp I has priced its IPO at $420 million as shares began trading on the Nasdaq on March 2.

Sponsored by Anzu Partners, a . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.

Related Articles

Back to top button

Get our daily news digest
in your inbox

Our FREE mailing list brings you daily alts intel.

Thank you for subscribing.

Something went wrong.